Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21818803rdf:typepubmed:Citationlld:pubmed
pubmed-article:21818803lifeskim:mentionsumls-concept:C1041819lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C0220806lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C0037813lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C1948027lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:21818803lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:21818803pubmed:issue17lld:pubmed
pubmed-article:21818803pubmed:dateCreated2011-8-5lld:pubmed
pubmed-article:21818803pubmed:abstractTextIn this study, a fast and reliable method based on an ultra-high-pressure liquid chromatography coupled with photodiode-array detection (PDA) and a linear ion trap high-resolution mass spectrometer (LTQ-Orbitrap XL) has been developed for the identification of bioactive constituents in the whole plant of Sarcandra glabra and its related four preparations. By accurate mass measurements within 5?ppm error for each molecular ion and subsequent fragment ions in routine analysis, 50 compounds, including organic acids, caffeoyl derivatives, flavonoids, coumarins and terpenoids, were identified or tentatively characterized. Among them, 6,7,8-trihydroxycoumarin-O-rhamnopyranoside (17), (2R)-naringenin-6-C-B-D-glucopyranosyl-(6?1)-apiose (25) and (2S)-naringenin-6-C-B-D-glucopyranosyl-(6?1)-apiose (27) were tentatively identified as new compounds. Besides, 21 of these compounds were coexisting in four preparations of Sarcandra glabra. Fragmentation behaviors of the four major categories of compounds were also investigated. This established UPLC-PDA/ESI-MS(n) method was reliable and effective for the separation and identification of the major constituents and would be the basis for quality control of Sarcandra glabra and its related preparations.lld:pubmed
pubmed-article:21818803pubmed:languageenglld:pubmed
pubmed-article:21818803pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:citationSubsetIMlld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21818803pubmed:statusMEDLINElld:pubmed
pubmed-article:21818803pubmed:monthSeplld:pubmed
pubmed-article:21818803pubmed:issn1097-0231lld:pubmed
pubmed-article:21818803pubmed:authorpubmed-author:VoasRRlld:pubmed
pubmed-article:21818803pubmed:authorpubmed-author:XiongLiLlld:pubmed
pubmed-article:21818803pubmed:authorpubmed-author:ZhangYufengYlld:pubmed
pubmed-article:21818803pubmed:authorpubmed-author:ZengXingXlld:pubmed
pubmed-article:21818803pubmed:authorpubmed-author:DengYuanhuiYlld:pubmed
pubmed-article:21818803pubmed:copyrightInfoCopyright © 2011 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:21818803pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21818803pubmed:day15lld:pubmed
pubmed-article:21818803pubmed:volume25lld:pubmed
pubmed-article:21818803pubmed:ownerNLMlld:pubmed
pubmed-article:21818803pubmed:authorsCompleteYlld:pubmed
pubmed-article:21818803pubmed:pagination2439-47lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:meshHeadingpubmed-meshheading:21818803...lld:pubmed
pubmed-article:21818803pubmed:year2011lld:pubmed
pubmed-article:21818803pubmed:articleTitleChemical profiling of bioactive constituents in Sarcandra glabra and its preparations using ultra-high-pressure liquid chromatography coupled with LTQ Orbitrap mass spectrometry.lld:pubmed
pubmed-article:21818803pubmed:affiliationSecond Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.lld:pubmed
pubmed-article:21818803pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21818803pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed